Health Catalyst Appoints Simeon Kohl as CEO with 2.75M RSU Inducement Grant
Question
Health Catalyst Appoints Simeon Kohl as CEO with 2.75M RSU Inducement Grant
Direct answer
Health Catalyst, Inc. announced the appointment of Simeon Kohl as CEO and President effective September 14, 2026, marking a leadership transition for the healthcare data analytics provider. In connection with the appointment, the compensation committee approved an inducement award of 2,747,385 restricted stock units pursuant to Nasdaq Listing Rule 5635(c)(4), structuring executive alignment over a two-year vesting timeline.
- Original publisher
- Market Ontology
- Evidence through
- 2026-09-15
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Health Catalyst Appoints Simeon Kohl as CEO with 2.75M RSU Inducement Grant”, revision 1, evidence through 2026-09-15. https://marketontology.com/market-events/2026-09-15/health-catalyst-appoints-simeon-kohl-as-ceo-with-2-75m-rsu-inducement-grant-d17c54
How this development reaches the affected companies
| Asset | Exposure and channel | Direction | Evidence |
|---|---|---|---|
| HCAT | executive leadership transition and equity dilution | Watch1-4w | Simeon Kohl appointed CEO with 2.75M RSU inducement award vesting over two years. |
Does this development affect your holdings?
Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
What happened next
Price follow-up pending — no stored daily closes for these assets yet.
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
Related
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.